Management
Malik Jainudeen
Acting Chief Executive Officer
Mr Malik Jainudeen was appointed to the role of Acting Chief Executive Officer for Monash IVF Group on 12 June 2025.
Malik joined Monash IVF Group in 2014 as a senior finance leader and has steadily progressed his career within the organisation. He has held the role of Chief Financial Officer and Company Secretary since 2019, contributing significantly to the Group’s financial strategy and governance.
Throughout his tenure, Malik has been instrumental in navigating complex regulatory environments, strengthening corporate governance, and enhancing operational efficiency, ensuring continued alignment with ASX compliance requirements and shareholder expectations.
With over 20 years of experience in the finance sector, Malik previously spent 10 years at KPMG as a Manager in Audit and Assurance. During this time, he managed audit engagements for several ASX-listed companies, including Origin Energy Limited, AusNet Services, and Dulux Group Limited. Prior to joining Monash IVF Group, he served as its External Audit Manager for six years leading up to the company’s listing on the ASX in 2014.
Malik holds a Bachelor of Business and is a qualified Chartered Accountant.
Fiona Allen
Chief Marketing Officer
Fiona Allen joined Monash IVF Group as Chief Marketing Officer in July 2019.
She is accountable for evolving the Monash IVF brand to meet the changing needs of the Australian community. She is also accountable for building customer awareness and advocacy, driving acquisition and retention, and creating experiences that customers love. A key areas of focus is driving innovation and simplicity in customer interactions.
Over the last 20 years Fiona has worked in senior marketing roles across a variety of sectors including healthcare, human services, financial services, professional services and FMCG. Most recently she worked with Medibank Health Solutions, GE Capital, and Simplot, helping them grow their brands and transition to a customer centric model and culture.
Fiona holds a Masters of Business Administration and a qualification in Marketing.
Tedd Fuell
Chief Governance & Risk Officer
Ms Tedd Fuell joined the Monash IVF Group in February 2016 as the Group Quality, Risk & Compliance Manager. Tedd has spent the last 18 years working in the healthcare industry in both project management and quality and compliance roles. Before joining the Monash IVF Group, Tedd worked for UK Pharmaceutical Group, Forum Bioscience and subsidiary Britannia Pharmaceuticals. Her last 10 years have been spent in the fertility industry working on quality, risk and compliance.
Tedd holds a Bachelor of Science (Biology) degree from the University of London.
Johannes Lagerwij
Asia Managing Director
Mr Johannes “Jan” Lagerwij joined the Monash IVF Group in March 2017 as the Asia Managing Director.
Jan’s role will be to further strengthen the organisation’s footprint in international markets by identifying and executing potential overseas partnerships and acquisitions to grow and expand the Monash IVF Group brand internationally. Jan comes with extensive global experience in mergers and acquisitions, joint ventures, co-development licensing and funding in the healthcare field.
Prior to his appointment with Monash IVF Group, he was an independent healthcare consultant advising strategic firms, venture capital and private equity in various strategic and transactional projects in China and Singapore.
Peggy North
Chief People & Culture Officer
Ms Peggy North joined the Monash IVF Group as Group Human Resources Manager in March 2017.
In her 16 years as a Human Resources specialist, she has worked in large multinational, public and private companies, developing HR action plans; designing, leading and facilitating change processes; applying change management methodologies; and, developing recommendations to promote HR policy, cultural and procedural change.
Prior to joining the Group, Peggy gained her Human Resources experience working for leading Australian and International FMCG organisations.
Peggy holds a Bachelor’s degree of Commerce, Human Resources Management and Services from the Swinburne University of Technology in Melbourne and is currently undertaking her MBA.
Thierry Panthier
Chief Information Officer
Mr Thierry Panthier joined Monash IVF in May 2019 and is responsible for continuing and expanding the group's digital transformation and cyber security initiatives. Before joining Monash IVF Group, Thierry worked in management roles for Mediaocean and Faiveley Transport.
Prof Luk Rombauts
Group Medical Director
Prof Luk Rombauts joined the Monash IVF Group in 1999, becoming Group Medical Director in 2016. Luk also holds positions as the Research Director at Monash IVF, Adjunct Clinical Professor at Monash University and Clinical Research Director of the Endometriosis Care Centre of Australia (ECCA). Luk is also the Vice-President of the Fertility Society of Australia (FSA) where he was appointed in 2011.
Prof Deirdre Zander-Fox
Chief Scientific Officer
Prof Deirdre Zander-Fox has worked in Assisted Reproduction since 2004. She is currently the Monash IVF Group Chief Scientific Officer as well as being Regional Scientific Director overseeing Monash IVF Victoria, Monash IVF Albury, and Malaysia. She is responsible for the scientific and research strategy for embryology, andrology, and endocrine services across the Monash IVF Group as well as directing laboratory operations for Victoria, Albury, and Malaysia. She is also chair of the Group Scientific Advisory Committee for the Monash IVF Group.
In addition to her clinical roles, Prof Zander-Fox also holds multiple academic positions including adjunct Professor at Monash University and A/Prof at the University of Adelaide as well as holding National Health and Medical Research Council (NHMRC) research funding including recently being a CI on the successful $15million MRFF grant to pilot Mitochondrial donation in Australia as part of a clinical trial. Professor Zander-Fox has authored a substantial number of peer-reviewed journal articles and book chapters with her research primarily focusing on improving laboratory technology that will directly benefit infertile patients including cryopreservation, microinjection technology, and culture media design.